Beware of a complex question, but I am quite interested in the R&D regimes in EU.
In BEPS action 5, all "patent box" regimes now include (or will soon include) a requirement that R&D expenditures must be done by "the company" to get full credit.
In EU, the best super-deductions are in Lithuania for example, with a 300% deduction for R&D. Now as countries change their patent box regimes more often than they change governments, it is potentially easy to get stuck with R&D developed in the wrong jurisdiction. Then if copyrights or patents are sold to another company in your group, you might risk losing the "developed by the company itself" status, and thus get into a higher tax bracket.
Using a UK TNR company with a permanent establishment in, say Lithuania would make it possible to later move the company to, say Switzerland. My question is whether the R&D can still be said to have been done by "the company" in this case?
In BEPS action 5, all "patent box" regimes now include (or will soon include) a requirement that R&D expenditures must be done by "the company" to get full credit.
In EU, the best super-deductions are in Lithuania for example, with a 300% deduction for R&D. Now as countries change their patent box regimes more often than they change governments, it is potentially easy to get stuck with R&D developed in the wrong jurisdiction. Then if copyrights or patents are sold to another company in your group, you might risk losing the "developed by the company itself" status, and thus get into a higher tax bracket.
Using a UK TNR company with a permanent establishment in, say Lithuania would make it possible to later move the company to, say Switzerland. My question is whether the R&D can still be said to have been done by "the company" in this case?